Site Haritası

Site Haritası

SNMMI 2017

Setting new standards with molecular imaging.

3:00 p.m.

June 10
 8:00 a.m.Introduction and Overview of FDA Regulations and Guidance  Documents related to PET Drug ChemistryRadiopharmaceuticalsMile High 2C
 12:30 p.m.Role of USP Monographs and General ChaptersRadiopharmaceuticalsMile High 2C
June 11
 3:00 p.m.Automated Motion Correction in  Quantitative SPECT Reconstruction:  a feasibility study of a method  framework applied first to bone imagingSPECTRoom 603
 3:00 p.m.Standardized Uptake Value Based  Assessment of Dual Phase  Parathyroid SPECT CT: Promising  Role in Equivocal CasesSPECTRoom 603
 7:00 p.m.Production of Fluciclovine1 F18 (FACBC) on a Siemens PETNET GN PlatformRadiopharmaceuticalsPoster 1772, Hall C
 7:00 p.m.Determination of extractables and leachables from several final  product filters used for the manufacturer of sterile  radiopharmaceuticalsRadiopharmaceuticalsPoster 1822, Hall C
June 12
 10:00 a.m.USP Standards for RadiopharmaceuticalsRadiopharmaceuticalsMile High 2C
 10:00 a.m.

Multi-Institutional Phantom Study of  Yttrium-90 PET-Based Dosimetry of  Hepatic Radioembolization using  PET/MRI: The MR-QUEST Study

PETRoom 705/707
 10:30 a.m.Impact of Respiratory Motion Compensation on PERSIST classification of Lung and Liver metastases in PET ImagingPETRoom 607
 3:30 p.m.Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and OpportunitiesRadiopharmaceuticalsMile High 4E-4F
 4:45 p.m.Quantitative Bias from Respiratory Motion and Finite System Resolution for SPECT Imaging of Kidneys – A Simulation StudySPECTRoom 605
June 13
 2:45 p.m.Respiratory Motion Compensation in PET/CT: Evaluation of a Fast Elastic Motion Compensation Technique Based on Motion DeblurringPET/CTPoster 1349, Hall C
 2:45 p.m.The Effects of Time-of-Flight and Point Spread Function Modeling on Regional Myocardial Blood Flow for Dynamic 82Rb PET of Large PatientsPET/CTPoster, Hall C
 2:45 p.m.A Second Generation SiPM Based PET/CT System1PET/CTPoster 1332, Hall C
 2:45 p.m.Automated Internal Dosimetry Research Tool using quantitative SPECT for the 177Lu Theranostic Application3SPECT/CTPoster 1301, Hall C
 2:45 p.m.Short-time Stress Only Gated Myocardial Perfusion IQ·SPECT in Clinical Routine: Initial ResultsSPECTPoster, Hall C
 3:00 p.m.Data Driven Motion Amplitude Characterization and Optimal Bin Determination in 4D PET – Realizing Personalized ImagingPET/CTRoom 705/707
 3:00 p.m.Automated Respiratory Phase Matching in PET/CT Using Fast Spiral CTPET/CTRoom 705/707
 3:00 p.m.Impact of Elastic Motion Correction on Quantitation and Image Quality of Whole-Body PET/CTPET/CTRoom 705/707
 3:00 p.m.PET Drug Manufacturing: Current Topics Related to the FDA and USPRadiopharmaceuticalsMile High 4E-4F
 4:45 p.m.Anatomy and Emission Based Non-Local Means Filtering for MR/PET and PET/CT DataMR/PET and PET/CTRoom 705/707
June 14
 9:45 a.mComparison of manual versus semi-automatic quantification of skeletal tumor burden on 18F-NaF4 PET/CTPET/CTRoom 603


1 Important safety information on Fluciclovine F 18 Injection (Axumin®) can be found on slide 4. The full prescribing information is available in the Siemens Healthineers booth.

2 This product is still under development and not commercially available yet. Its future availability cannot be guaranteed.

3 177Lu is not commercially available in some countries, including the US. 177Lu is not currently recognized by the US FDA as being safe and effective, and Siemens does not make any claims regarding its use. Please contact your local Siemens organization for further details.

4 Important safety information on 18F-NaF can be found on slide 9. The full prescribing information is available in the Siemens Healthineers booth.

Bu bilgi yardımcı oldu mu?
Yanıtınız için teşekkür ederiz
Yorumunuzda sayı ve/veya '@' işareti olduğunu fark ettik. Sizinle iletişime geçmemiz için telefon numarası ya da e-posta adresi girmeye çalışıyorsanız lütfen bizimle e-posta formumuz aracılığıyla iletişime geçiniz.

Not: Doğrudan kişisel bir yanıt almak için lütfen bizimle e-posta formumuz üzerinden iletişime geçiniz.

Teşekkür ederiz